Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Aurinia Pharmaceuticals: All In On Lupkynis - A Tough Bet
12:53am, Friday, 24'th Mar 2023
LUPKYNIS has had a lengthy and ultimately productive development pathway. Aurinia has gone all hands on deck to provide LUPKYNIS a successful launch.
Aurinia Pharmaceuticals Inc. (AUPH) Q4 2022 Earnings Call Transcript
02:48pm, Tuesday, 28'th Feb 2023
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH ) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Dana Lynch - Director of Corporate Communications & Corporate Affairs Pet
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
08:17am, Tuesday, 28'th Feb 2023
Aurinia (AUPH) delivered earnings and revenue surprises of 30.77% and 0.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Drug, Biotech Stocks Poised to Beat Q4 Earnings Estimates
09:02am, Thursday, 23'rd Feb 2023
We look at a few drug/biotech companies, TBPH, FGEN, AUPH, CYTK, which are poised to beat on earnings in the fourth quarter.
These 2 Healthcare Stocks Have Doubled in 2023
07:06am, Thursday, 02'nd Feb 2023
Many traders are attracted to low-priced stocks because they come with the allure of 2x, 3x or greater short-term gains. For fundamentalists, the challenge is finding such companies that have establis
Why Shares of Aurinia Pharmaceuticals Soared This Week
04:49pm, Friday, 06'th Jan 2023
A patent settlement and improved financials sent the stock soaring.
Aurinia's Patent Dispute Is Over, But Without A Buyout, There's No Upside
12:29pm, Thursday, 05'th Jan 2023
Aurinia Pharmaceuticals Inc. recently settled a patent dispute with Sun Pharma. That seems to have rekindled buyout chatter.
Aurinia Pharmaceuticals: Lupkynis Patent Settlement Removes Overhang
07:30am, Thursday, 05'th Jan 2023
Aurinia Pharmaceuticals recently announced they have reached a settlement with Sun Pharmaceuticals concerning the patent challenge for Lupkynis. Both companies will dismiss their claims and countercla
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
05:00pm, Wednesday, 04'th Jan 2023 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:AUPH) stock. These analysts are typically employed by large Wall Street banks and tasked with underst
Aurinia Pharmaceuticals to Present at Upcoming 41st Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 04'th Jan 2023
VICTORIA, British Columbia--( BUSINESS WIRE )--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Peter Greenleaf, President and Chief Executive Officer, is sche
Aurinia (AUPH) Soars 37.5%: Is Further Upside Left in the Stock?
09:47am, Wednesday, 04'th Jan 2023 Zacks Investment Research
Aurinia (AUPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
Aurinia (AUPH) Soars 37.5%: Is Further Upside Left in the Stock?
06:01am, Wednesday, 04'th Jan 2023
Aurinia (AUPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
Tesla, Amazon, Apple, Aurinia Pharma, Vera Therapeutics: Why These 5 Stocks Are Drawing Investors' Attention Today
01:09am, Wednesday, 04'th Jan 2023 Benzinga
Major Wall Street indices closed in the red on Tuesday, the first trading day of 2023, as concerns over rising rates and inflation still seem to drive investor sentiments. The Nasdaq Composite closed
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
06:39pm, Tuesday, 03'rd Jan 2023 Benzinga
Gainers
Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Jasper Therapeutics, Inc. (NASDAQ: JSPR) gained 257
Biotech Stock Blasting Higher After Settlement
02:52pm, Tuesday, 03'rd Jan 2023
The shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) are soaring today, after the company announced a patent settlement agreement with Sun Pharmaceutical Industries Ltd (SUN) related to its lupus n
